V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 250002234 | 250007072 | 1.56 | 91 | Palliative (P) | 2018-07-17 | 2018-07-18 | Trial Unspecified | 02 | N | STS RHABDO VIT0910 VINC IRINO TEMOZ | 101705633 |
| 250002235 | 250007073 | null | null | Palliative (P) | null | 2020-12-26 | GEMCARBO | null | N | DACARBAZINE | 100823765 |
| 250002237 | 250007074 | 1.9 | 98.3 | Palliative (P) | 2019-08-17 | 2019-09-13 | Trial Unspecified | 02 | N | CARBOPLATIN + VINORELBINE | 100773104 |
| 250002238 | 250007075 | 1.87 | 70 | Palliative (P) | 2020-04-22 | 2020-04-29 | CARBOPLATIN | 02 | N | CAPECITABINE + OXALIPLATIN | 101471444 |
| 250002239 | 250007076 | 1.76 | 91 | Palliative (P) | null | 2018-09-04 | BEP 5 Day | 02 | N | WT GUIDELINES CYCLOPHOS/DOXORUBICIN | 101525680 |
| 250002240 | 250007077 | 1.93 | null | Palliative (P) | 2017-06-19 | 2017-06-27 | ETOPOSIDE + MELPHALAN | 02 | N | IFOSFAMIDE | 100812506 |
| 250002243 | 250007078 | 1.58 | 66.4 | Palliative (P) | 2020-02-09 | 2020-02-09 | null | 02 | N | CARBOPLATIN | 101222663 |
| 250002244 | 250007079 | null | null | null | 2018-01-04 | 2018-02-01 | CARBOPLATIN + PACLITAXEL | N | null | TRIAL UNSPECIFIED | 100119709 |
| 250002245 | 250007080 | 1.68 | 54 | Palliative (P) | 2016-09-19 | 2016-09-20 | null | 01 | Y | CYCLOPHOSPHAMIDE + TOPOTECAN | 100936287 |
| 250002251 | 250007084 | null | null | null | 2018-09-01 | 2018-09-15 | Atezolizumab | 02 | null | FLUOROURACIL + MITOMYCIN | 100520843 |
| 250002254 | 250007085 | 1.74 | 65.5 | Palliative (P) | 2020-06-09 | 2020-06-17 | null | 02 | null | STS RHABDOMYOSARCOMA RMS 2005 IVA | 100575057 |
| 250002255 | 250007086 | null | null | Palliative (P) | null | 2019-06-16 | Irinotecan + Modified De Gramont | null | Y | ETOPOSIDE + IFOSFAMIDE | 100518658 |
| 250002266 | 250007090 | null | null | Palliative (P) | null | 2022-02-27 | Atezolizumab | null | N | CYCLOPHOSPHAMIDE + VINORELBINE | 100799075 |
| 250002270 | 250007093 | 1.79 | 92.2 | null | null | 2017-07-20 | DACARBAZINE + GEMCITABINE | 02 | N | WT GUIDELINES VINC/ACTINOD | 100469364 |
| 250002272 | 250007095 | 1.6 | 14.7 | null | 2019-03-15 | 2019-03-15 | null | 02 | null | CYCLOPHOSPHAMIDE | 100196390 |
| 250002277 | 250007096 | 1.89 | null | Palliative (P) | 2017-12-07 | 2017-12-14 | CISPLATIN + FLUOROURACIL | 02 | N | CARBOPLATIN + PEMETREXED | 100267243 |
| 250002279 | 250007097 | 1.67 | 62 | Palliative (P) | 2020-02-23 | 2020-02-24 | Gemcitabine weekly | N | N | DOCETAXEL | 101420799 |
| 250002280 | 250007098 | 0 | 51.2 | Palliative (P) | 2016-10-11 | 2016-10-11 | null | 02 | N | IPILIMUMAB + NIVOLUMAB | 100171267 |
| 250002281 | 250007099 | null | null | Palliative (P) | null | 2017-05-29 | Oxaliplatin + Modified de Gramont | 02 | N | IPILIMUMAB + NIVOLUMAB | 100043914 |
| 250002282 | 250007100 | 1.69 | 106 | null | null | 2017-12-17 | Bevacizumab 7.5mg/kg | 02 | N | CAPECITABINE + CISPLATIN | 100423959 |
| 250002283 | 250007101 | null | null | Palliative (P) | null | 2019-09-06 | IPILIMUMAB + NIVOLUMAB | null | null | TRIAL UNSPECIFIED | 100663940 |
| 250002286 | 250007102 | null | 91.3 | Palliative (P) | 2018-07-27 | 2018-09-04 | null | 02 | N | CARBOPLATIN + PACLITAXEL | 100551826 |
| 250002287 | 250007103 | null | null | null | null | 2018-11-06 | Docetaxel + Gemcitabine (prior RT) | null | Y | TRIAL UNSPECIFIED | 100041109 |
| 250002292 | 250007105 | 1.53 | 28.9 | null | 2019-08-09 | 2019-08-13 | VAC | 02 | null | NB HRNBL-1 CH14.18/CHO ONLY (TRIAL) | 101447840 |
| 250002293 | 250007106 | null | null | null | 2018-03-06 | 2018-03-10 | Carbo F | null | null | CARBOPLATIN | 100462395 |
| 250002303 | 250007111 | 1.67 | 10.7 | null | 2019-02-16 | 2019-03-11 | CARBOPLATIN + FLUOROURACIL | Y | N | DOXORUBICIN | 100982714 |
| 250002306 | 250007113 | null | null | Palliative (P) | 2018-11-03 | 2018-11-29 | null | 02 | N | DOCETAXEL + GEMCITABINE | 101569819 |
| 250002307 | 250007114 | null | 13.1 | null | 2019-10-20 | 2019-11-02 | Gemcitabine 1000mg/m2 D1 8 15 | null | N | EW EUROEWING 2012 ARM B VDC/IE | 101329965 |
| 250002308 | 250007115 | 1.76 | 46.4 | Palliative (P) | 2019-09-24 | 2019-10-16 | Cetuximab + CISPLATIN + FLUOROURACIL | 02 | Y | CETUXIMAB + IRINOTECAN + MDG | 101513232 |
| 250002309 | 250007116 | null | null | Palliative (P) | 2017-10-29 | 2017-10-31 | null | 02 | N | NIRAPARIB | 101720961 |
| 250002310 | 250007117 | null | null | null | null | 2018-09-18 | Trial Unspecified | N | null | TRIAL UNSPECIFIED | 100066307 |
| 250002312 | 250007118 | null | null | Palliative (P) | null | 2019-09-04 | Trabectedin | null | N | CARBOPLATIN + PACLITAXEL | 101565576 |
| 250002313 | 250007119 | 1.65 | 98.8 | Adjuvant (A) | 2019-04-07 | 2019-05-28 | CABOZANTINIB | 02 | N | CAPECITABINE + IRINOTECAN | 101535452 |
| 250002314 | 250007120 | null | null | Palliative (P) | null | 2017-09-26 | CISPLATIN + RT | 02 | Y | PACLITAXEL | 101026921 |
| 250002319 | 250007121 | 1.67 | 28.9 | Palliative (P) | 2019-03-07 | 2019-03-31 | null | 02 | null | BEVACIZUMAB | 101205298 |
| 250002320 | 250007122 | 1.69 | 80 | Curative (C) | 2019-08-26 | 2019-09-24 | NB HRNBL-1 ch14.18/CHO only (trial) | 02 | N | WT SIOP 2002 01 POST OP CARBO, ETOP | 101137656 |
| 250002324 | 250007123 | 1.81 | 126 | null | 2017-09-09 | 2019-06-20 | Cisplatin + Pemetrexed | 02 | N | ENZALUTAMIDE | 101411743 |
| 250002327 | 250007125 | 1.69 | 92.2 | Palliative (P) | null | 2018-10-28 | Gemcitabine day 1&8 | null | null | STS RHABDOMYOSARCOMA RMS 2005 IVA | 101013810 |
| 250002333 | 250007129 | 1.62 | 59 | Palliative (P) | null | 2021-01-10 | FLUOROURACIL + MITOMYCIN + RT | 02 | null | STS RHABDO RMS 2005 VIN CYCLO | 101519263 |
| 250002334 | 250007130 | 0 | 53.5 | Palliative (P) | 2019-08-22 | 2019-08-23 | TEMOZOLOMIDE | 02 | N | ICON8B TRIAL | 101637139 |
| 250002344 | 250007133 | 1.85 | 125.6 | null | 2019-06-12 | 2019-06-12 | VIDE | 02 | N | GEMCITABINE | 101069981 |
| 250002349 | 250007134 | 1.78 | 99.3 | null | 2018-06-15 | 2018-07-04 | IMATINIB | 02 | N | AVELUMAB + AXITINIB | 101207029 |
| 250002360 | 250007137 | null | null | null | 2020-05-09 | 2020-05-21 | null | 02 | N | DACTINOMYCIN + IFOSFAMIDE + VINCRISTINE | 101227963 |
| 250002363 | 250007138 | 1.69 | 63 | null | 2021-02-04 | 2021-02-19 | Pemetrexed | null | null | ATEZOLIZUMAB | 100936005 |
| 250002366 | 250007139 | 1.63 | 12 | null | 2020-02-15 | 2020-02-27 | Carbo F | 02 | null | TRIAL UNSPECIFIED | 100195240 |
| 250002373 | 250007140 | null | null | null | null | 2019-03-19 | POUT TRIAL | null | N | DOCETAXEL | 100387475 |
| 250002375 | 250007141 | 1.59 | 99.3 | Palliative (P) | 2022-03-28 | 2022-04-16 | CETUXIMAB | 02 | N | BACILLUS CALMETTE-GUERIN | 100898708 |
| 250002381 | 250007143 | 1.71 | 87 | Palliative (P) | 2018-12-26 | 2019-01-22 | null | 02 | N | CARBOPLATIN + PACLITAXEL | 101735266 |
| 250002383 | 250007144 | 1.78 | 114.2 | Palliative (P) | 2018-07-10 | 2018-07-11 | Trial Unspecified | 02 | N | CARBOPLATIN + RT | 101814106 |
| 250002384 | 250007145 | null | null | null | null | 2016-12-11 | null | null | null | FLUOROURACIL + MITOMYCIN | 101724276 |